Liver Failure and Liver Disease

You have full text access to this OnlineOpen article

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C†

  1. Marianne Ziol1,
  2. Adriana Handra-Luca1,
  3. Adrien Kettaneh2,
  4. Christos Christidis3,
  5. Frédéric Mal3,
  6. Farhad Kazemi4,
  7. Victor de Lédinghen5,
  8. Patrick Marcellin6,
  9. Daniel Dhumeaux7,
  10. Jean-Claude Trinchet8,
  11. Michel Beaugrand9,‡,*

Article first published online: 22 DEC 2004

DOI: 10.1002/hep.20506

Issue

Hepatology

Hepatology

Volume 41, Issue 1, pages 48–54, January 2005

Additional Information

How to Cite

Ziol, M., Handra-Luca, A., Kettaneh, A., Christidis, C., Mal, F., Kazemi, F., de Lédinghen, V., Marcellin, P., Dhumeaux, D., Trinchet, J.-C. and Beaugrand, M. (2005), Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology, 41: 48–54. doi: 10.1002/hep.20506

Author Information

  1. 1

    UPRES EA 3406, University of Paris 13, Bobigny, France, and Department of Pathology, AP-HP, Jean Verdier Hospital, Bondy, France

  2. 2

    UPRES EA 3409, University of Paris 13, Bobigny, France, and Department of Internal Medicine, AP-HP, Jean Verdier Hospital, Bondy, France

  3. 3

    Department of Hepatology and Gastroenterology, AP-HP, Jean Verdier Hospital, Bondy, France, and Department of Digestive Diseases, Institut Mutualiste Montsouris, Paris, France

  4. 4

    Department of Hepatology and Gastroenterology, AP-HP, Jean Verdier Hospital, Bondy, France

  5. 5

    Department of Hepatology and Gastroenterology, Haut Lévêque Hospital, Pessac, France

  6. 6

    Department of Hepatology and INSERM U481, Beaujon Hospital, Clichy, France

  7. 7

    Department of Hepatology and Gastroenterology, AP-HP, Henri Mondor Hospital, Créteil, France

  8. 8

    UPRES EA 3409, University of Paris 13, Bobigny, France, and Department of Hepatology and Gastroenterology, AP-HP, Jean Verdier Hospital, Bondy, France

  9. 9

    UPRES EA 3410, University of Paris 13, Bobigny, France, and Department of Hepatology and Gastroenterology, AP-HP, Jean Verdier Hospital, Bondy, France

  1. ‡

    fax: (33)1 48 02 62 02

*Service d'Hépato-gastro-entérologie, Hôpital Jean Verdier, avenue du 14 juillet, 93143 Bondy Cedex, France

  1. †

    Conflict of interest: M. Z. is supported by a research grant from EchoSens®.

  2. ‡

    fax: (33)1 48 02 62 02

Publication History

  1. Issue published online: 23 DEC 2004
  2. Article first published online: 22 DEC 2004
  3. Manuscript Accepted: 25 SEP 2004
  4. Manuscript Received: 30 MAR 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (139K)

References

  • 1
    Poynard T, Yuen MF, Ratziu V, Lung Lai C. Viral hepatitis C. Lancet 2003; 362: 2095–2100.
  • 2
    Bonny C, Rayssiguier R, Ughetto S, Aublet-Cuvelier B, Baranger J, Blanchet G, et al. Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region. Gastroenterol Clin Biol 2003; 27: 1021–1025.
  • 3
    Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. HEPATOLOGY 2003; 38: 1449–1457.
  • 4
    Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pizie D, et al. Sampling variability and the influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523–525.
  • 5
    Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614–2618.
    Direct Link:
  • 6
    Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WH. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 1971; 16: 1082–1086.
  • 7
    Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979; 139: 667–669.
  • 8
    Sandrin L, Tanter M, Gennisson JL, Catheline S, Fink M. Shear elasticity probe for soft tissues with 1D transient elastography. Ultrason Ferroelectr Freq Control 2002; 49: 436–446.
  • 9
    Bedossa P, Poynard T. An algorithm for grading of activity in chronic hepatitis C. HEPATOLOGY 1996; 24: 289–293.
    Direct Link:
  • 10
    Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705–1713.
  • 11
    The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. HEPATOLOGY 1994; 20: 15–20.
    Direct Link:
  • 12
    Hanley JA, McNeil BJ. The meaning and use of the area under the Receiver Operating Characteristic (ROC) curve. Radiology 1982; 143: 29–36.
  • 13
    Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839–843.
  • 14
    Steyerberg EW, Harrell FE Jr, Borsboom GJJM, Eijkemans MJC, Vergouwe Y, Habbemia JDF. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001; 54: 774–781.
  • 15
    Fung YC. Biomechanical Properties of Living Tissues. New York: Springer Verlag, 1981.
  • 16
    Yeh WC, Li PC, Jeng YM, Hsu HC, Kuo PL, Li ML, et al. Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med Biol 2002; 28: 467–474.
  • 17
    Saadeh S, Cammel G, Carey WD, Youmossi Z, Barns D, Easley K. The role of liver biopsy in chronic hepatitis C. HEPATOLOGY 2001; 33: 196–200.
    Direct Link:
  • 18
    Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000; 14: 543–48.
  • 19
    Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495–500.
  • 20
    Batts KP, Ludwig J. Chronic hepatitis an update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409–1417.
  • 21
    Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003; 38: 427–432.
  • 22
    Teare JP, Sherman D, Greenfield SM, Simpson J, Bray G, Catteral AP, et al. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Lancet 1993; 342: 895–898.
  • 23
    Gabrielli GB, Capra F, Casaril M, Squarzoni S, Tognella P, Dagradi R, et al. Serum laminin and type III procollagen in chronic hepatitis C: diagnostic value in the assessment of disease activity and fibrosis. Clin Chim Acta. 1997; 265: 21–31.
  • 24
    Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen aminoterminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996; 42: 558–563.
  • 25
    Naveau S, Poynard T, Benattar C, Bedossa P, Chaput JC. Alpha-2-macroglobulin and hepatic fibrosis: diagnostic interest. Dig Dis Sci 1994; 39: 2426–2432.
  • 26
    Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepatol 1998; 5: 187–192.
    Direct Link:
  • 27
    Wai CT, Greenson JK, Fontana RJ, Kalfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. HEPATOLOGY 2003; 38: 518–526.
    Direct Link:
  • 28
    Forns X, Ampurdanès S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. HEPATOLOGY 2003; 36: 986–992.
  • 29
    Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069–1075.
  • 30
    Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 2003; 49: 450–454.
  • 31
    Halfon P, Bourliere M, Deydier R, Portal I, Renou C, Bertrand JJ, et al. Independent prospective multicenter validation of biochemical markers (Fibrotest-Actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C. 54th Annual Meeting of the AASLD, HEPATOLOGY 2003; 38: 188A.
View Full Article (HTML) Get PDF (139K)